Details for Patent: 10,265,404

Which drugs does patent 10,265,404 protect, and when does it expire?

Patent 10,265,404 protects AMZEEQ and ZILXI and is included in two NDAs.

This patent has twenty-two patent family members in ten countries.

Summary for Patent: 10,265,404

Title:	Compositions, gels and foams with rheology modulators and uses thereof
Abstract:	The present disclosure relates generally to compositions for cosmetic or pharmaceutical application. The compositions include a carrier and rheology modulators.
Inventor(s):	Dov Tamarkin, Elana Gazal, Yohan HAZOT, David Schuz, Irakliy PAPIASHVILI
Assignee:	Journey Medical Corp
Application Number:	US14/078,746
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,265,404
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 10,265,404

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Journey	AMZEEQ	minocycline hydrochloride	AEROSOL, FOAM;TOPICAL	212379-001	Oct 18, 2019		RX	Yes	Yes			Y
Journey	ZILXI	minocycline hydrochloride	AEROSOL, FOAM;TOPICAL	213690-001	May 28, 2020		RX	Yes	Yes			Y

International Family Members for US Patent 10,265,404

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2010302350
Australia	2015224534
Brazil	112012007473